Chemical Business Newsbase articles from June 2009, page 8

Chemical Business Newsbase archives from June 2009

Dow Corning urges US policies to boost solar.
June 29, 2009... Dow Corning, a US-based producer of silicon-based materials, is calling on US lawmakers to pass legislation to boost the solar energy industry and make the country a 21st century solar power. The firm suggests introduction of renewable energy...

Pertamina picks Dow Unipol PP technology.
June 29, 2009... PT Pertamina, Indonesia's state-owned energy and chemical company, will use Dow Chemical's UNIPOL Polypropylene (PP) Process technology at its proposed 250,000 tonne/y plant in Balongan, West Java, Indonesia. The plant is expected to be...

Monsanto 3Q 2009 profit falls; will cut 900 jobs.
June 29, 2009... Monsanto, a seed and herbicide supplier based in the USA, reported a net profit of $694 M (EUR 493 M) for fiscal 3Q 2009, down by 14%. Sales fell 11% to $3.16 bn. The disappointing results have prompted the company to announce a restructuring...

Evonik to expand global methionine capacity.
June 29, 2009... German firm Evonik plans to ramp up its methionine capacity in the USA, Belgium and Germany beginning in 2011. The company's goal is to raise its capacity for the feed additive to 430,000 tonnes/y by 2013.

Showa Shell, Saudi Aramco plan solar jv.
June 29, 2009... Japanese refiner Showa Shell Sekiyu and Saudi Arabia's state-controlled oil firm Saudi Aramco Oil have agreed to study the feasibility of a solar power jv. The partners plan to build small-scale solar power plants in off-the-grid areas in Saudi...

BASF site leaks 10 tonnes of HPN into Rhine.
June 29, 2009... A chemical used in the production of lacquers has found its way into the river Rhine in Germany due to a leak at BASF's Ludwigshafen site. Ten tonnes of hydroxypivalic acid neopentyl glycol ester (HPN) has escaped through the cold water system....

Oltchim to temporarily cut around 1000 jobs.
June 29, 2009... Romanian state-controlled chemical producer Oltchim will put about 1000 employees at its Ramnicu Valcea site on an at least one-month furlough in an effort to cut costs. The company has been running at 40% of its usual production capacity as a...

Lukoil buys Dow's stake in Total refinery.
June 29, 2009... Russian firm Lukoil has acquired Dow Chemical's 45% stake in a refinery in Vlissingen, Netherlands as part of its strategy to invest in markets where there is demand for high value added products. French firm Total is the majority owner of the...

PKN Orlen introduces voluntary redundancy.
June 29, 2009... PKN Orlen, an oil, chemical and petrochemical group based in Poland, is offering voluntary severance packages as part of a five-year plan to reduce its workforce by 19%. Employees who volunteered to leave by end-Jul 2009 will receive Zloty...

Total sacks 900 strikers at UK refinery.
June 29, 2009... Total has dismissed up to 900 UK employees who have been on unofficial strike since 11 Jun 2009. The employees were contracted to work on the company's hydrodesulfurization project at an oil refinery in Lindsey, UK.

Flooding eyed in deadly ethanol derailment.
June 29, 2009... A Canadian National Railway train carrying ethanol near Rockford, IL, USA was involved in an accident on 19 Jun 2009, resulting in one fatality and three injuries. The derailment of the train's 18 cars on tracks that had been possibly washed out...

Clariant to cut 500 more jobs in restructuring.
June 29, 2009... Clariant will eliminate another 500 jobs in its second-phase restructuring programme for 2009. A previous announcement made in early 2009 involved 1350 job cuts.

CF Industries extends offer for Terra.
June 29, 2009... US fertilizer producer CF Industries has extended the deadline of its takeover offer for Terra Industries to 10 Jul 2009. The offer to acquire all of the outstanding shares of Terra Industries common stock would have expired on 26 Jun 2009.

Goodyear to reduce production.
June 29, 2009... Goodyear Tire and Rubber will operate on a three-shift, five-day workweek in North America beginning 6 Jul 2009. The shift from a continuous operating schedule was prompted by lacklustre demand.

Dow Automotive opens new plant in Germany.
June 29, 2009... An automotive adhesives plant in Schkopau, Saxon-Anhalt, Germany has been inaugurated by Dow Automotive. The new plant generated 180 jobs.

Akzo may close German site in 2010.
June 29, 2009... AkzoNobel Polymer Chemicals may shutter a plant in Emmerich, Germany that produces peroxides and pastes by end-2010. The move will affect 34 jobs.

INEOS in 'growth' talks for Grangemouth.
June 29, 2009... INEOS is reportedly in discussions with potential investors in its refinery and petrochemical complex in Grangemouth, Scotland. One of the possible investors is Chinese oil and gas company PetroChina.

China flooding USA with cheap tyres: regulator.
June 29, 2009... The US market is overflowed with tyre imports from China, according to findings by the US International Trade Commission. The demand for styrene butadiene rubber could be affected by the glut in Chinese tyre imports.

Evonik Cyro to revamp N America operations.
June 29, 2009... Acrylic sheet and moulding compounds producer Evonik Cyro plans to streamline its North American operations, leading to a loss of about 56 jobs. The plan is prompted by the falling demand from the auto, building and retail display sectors.

Russia levies duty on imported polyethers.
June 29, 2009... An import duty on polyethers has been approved by Russia, effective through 15 Mar 2010. A duty of 10%, and at least EUR 0.35/kg ($0.49), will be in force from 16 Jul 2009.

Chemical market trends: feedstocks bump up prices.
June 29, 2009... Pricing trends are discussed for ethylene, ethylene glycol, vinyl chloride monomer, propylene, butadiene, styrene butadiene rubber, bisphenol A, paraxylene, purified terephthalic acid, styrene acrylonitrile and acrylonitrile. The initial...

Chemical profile: MTBE. [1 figure, 1 table in original article].
June 29, 2009... Methyl tertiary ether (MTBE), which is applied nearly exclusively as a fuel ingredient in gasoline, is forecast to see a continued decline in demand in Europe. However, MTBE consumption in other parts of the world such as Asia, Africa and the...

Dow announces plan to build and operate a pilot-scale algae-based integrated biorefinery with Algenol Biofuels.
June 29, 2009... The Dow Chemical Co plans to work with Algenol Biofuels Inc to build and operate a pilot-scale algae-based integrated biorefinery that will convert CO2 into ethanol. The facility is planned to be located at Dow's Freeport, TX site. Algenol's...

CF ignores clear stockholder message: disregards compelling majority of CF shares tendered in support of Agrium offer.
June 29, 2009... On 29 Jun 2009, Agrium Inc commented on its efforts to conclude a mutually beneficial transaction with CF Industries Holdings Inc. Mike Wilson, Agrium's President and CEO, stated, "Following a successful stockholder referendum on Agrium's offer...

Alizyme: trading update.
June 29, 2009... On 29 Jun 2009, Alizyme plc gave an update on the company's financial position. Alizyme has licensing and development agreements with regard to COLAL-PRED with various parties. These agreements provide for payments to Alizyme tied to the...

Bayer CropScience and Monsanto sign cross licensing agreement on herbicide tolerance traits in rapeseed/canola.
June 29, 2009... Bayer CropScience AG and Monsanto Co have agreed to cross license their respective herbicide tolerance traits in rapeseed/canola on a non-exclusive basis for commercialization within their respective branded canola seed businesses. Canola is a...

Bayer Schering Pharma extends research portfolio in the field of cancer-related targets.
June 29, 2009... Bayer Schering Pharma AG, Germany, has entered into an exclusive license agreement with Celera Corp, CA, providing Bayer Schering Pharma with access to five cancer-related targets for therapeutic development and in-vivo diagnostic imaging. These...

Vianex will market Bilastine in Greece.
June 29, 2009... Vianex, the leading Greek pharmaceutical company, will market the antihistaminic product Bilastine, researched and developed by the Spanish company Faes Farma. Faes Farma and Menarini, which has license on the compound for 51 countries, enter...

Lanxess: Production in Singapore to start in 2014.
June 29, 2009... Due to the continuing global economic crisis, specialty chemicals group Lanxess AG is postponing the construction of its new butyl rubber facility in Singapore. Production is now scheduled to start in 2014. Lanxess will use the time to finish...

Lanxess and Hankook Tire sign long-term butyl rubber supply agreement.
June 29, 2009... German specialty chemicals company Lanxess AG and South Korean tire manufacturer Hankook have further strengthened their collaboration by signing a five-year supply agreement where Lanxess will supply large volumes of butyl rubber to Hankook...

Saltigo targets Japanese custom manufacturing market.
June 29, 2009... Custom manufacturing specialist Saltigo GmbH is presenting its comprehensive portfolio of services at Interphex/Pharma-i Japan Exhibition in Tokyo on 1 to 3 Jul 2009. Saltigo's CEO Wolfgang Schmitz emphasizes: "This is Asia's largest...

Rubber pioneer presents new developments at the International Rubber Conference 2009.
June 29, 2009... The year 2009 has a special place in the history of the specialty chemicals group Lanxess AG, with the company celebrating the 100th anniversary of the invention of synthetic rubber. New developments introduced by the comapny at the...

Polymer additive Mesamoll - the green alternative.
June 29, 2009... As part of its Green Chemistry initiative, the specialty chemicals group Lanxess AG is launching Krynac M 3340 VP, a new grade of nitrile rubber that contains a plasticizer which is not considered as hazardous substance. In doing so, the Lanxess...

Energy from the depths of the Earth: Synthetic rubbers help harness geothermal power.
June 29, 2009... Geothermal energy, using heat from the Earth for electricity generation and heating, is seen as an energy source with a future. However, the holes through which the underground heat stores are tapped place major demands on tools that are wholly...

Safe ingredients for improved rubber formulations: Lanxess to stop using oils containing high levels of PAH worldwide.
June 29, 2009... The Performance Butadiene Rubbers (PBR) business unit of the synthetic rubber manufacturer Lanxess plans to extensively forgo the use of processing oils with high polycyclic aromatic hydrocarbon (PAH) content worldwide by the end of 2009. Some...

Plastics recycling on the rise in Canada, report says.
June 29, 2009... Canadians now have better access to recycled plastics, says the Environment and Plastics Industry Council. Access to all types of consumer plastic recycling rose from 44% in 2005 to 53% in 2009. Notable is the increase in non-beverage PET...

A Schulman to end production of Invision-brand plastic sheet.
June 29, 2009... A Schulman Inc announced on 29 Jun 2009 that it will cease making Invision plastic sheets later in 2009. The company will halt production of the material at its factory in Sharon Center, OH, USA, saying that maintaining the operation is...

Investments by Brazil Petrobras secured for up to 5 years - CEO.
June 29, 2009... Funds raised by Brazilian oil company Petrobras in Jan - May 2009 period, which totalled $31 bn considering a R$ 2 exchange rate, could finance investments by the company till 2010 to 2013 period, depending on international oil prices. Of...

Brazil Petrobras R$ 2.6 bn Jan-Apr surplus cut from public accounts.
June 29, 2009... Brazil's federal oil giant Petroleo Brasileiro S/A (Petrobras) accumulated a R$ 2.643 bn primary budget surplus in Jan 2009 through Apr 2009, the Central Bank Economic Studies Department said on 29 Jun 2009. The figure has been excluded from...

Brazil MMX says no longer a partner of Anglo American.
June 29, 2009... Brazilian mining and metals company MMX, of tycoon Eike Batista's EBX group said on 29 Jun 2009 that, contrary to news reports, it is no longer a partner of Anglo American in mining projects. In 2008, MMX sold 100% of Minas-Rio and 70% of the...

FDA decision on Feraheme NDA expected within next few days from 29 Jun 2009.
June 29, 2009... Amag Pharmaceuticals Inc has not received an action letter from the US Food and Drug Administration (FDA) for Feraheme (ferumoxytol) Injection for the treatment of iron deficiency anaemia in adult chronic kidney disease patients. The...

Genta Inc announces delay in implementation of reverse common stock split.
June 29, 2009... Genta Inc announced that a previously announced reverse stock split will not be effective with the opening of trading on 1 Jul 2009. At a Special Meeting of stockholders held on 26 Jun 2009, Genta's stockholders approved a proposal to...

AGTC and National Neurovision Research Institute collaborate, funding research in two genetic retinal diseases.
June 29, 2009... Applied Genetic Technologies Corp (AGTC) announces that AGTC has entered into an agreement with the National Neurovision Research Institute (NNRI), the clinical trial support organization for the Foundation Fighting Blindness (FFB), to...

Medactive Oral Pharmaceuticals LLC announces exclusive Licence and Supply Agreement with WhiteHill Oral Technologies Inc.
June 29, 2009... Medactive Oral Pharmaceuticals LLC (Medactive) has entered into a Licence/Supply Agreement with WhiteHill Oral Technologies Inc that provides Medactive exclusive rights to produce and market a new generation of oral care pharmaceuticals. The...

Juvaris BioTherapeutics announces strategic collaboration with Antigen Discovery Inc.
June 29, 2009... Juvaris BioTherapeutics Inc (Juvaris) announced the signing of a definitive agreement with Antigen Discovery Inc (ADi) to access ADi's proprietary high-throughput protein microarray screening system to discover novel disease-specific antigens...

Analysis of Dynamotive upgraded BioOil confirms gasoline, jet, diesel and vacuum gasoil fractions.
June 29, 2009... Dynamotive Energy Systems Corp (Dynamotive) announced that independent analyses of upgraded BioOil samples have established the potential for development of synthetic hydrocarbon mobile fuels. Distillation analysis of the samples provided...

PPD confirms Takeda receives FDA complete response for alogliptin.
June 29, 2009... PPD Inc announced that Takeda Pharmaceutical Co Ltd (Takeda) issued a news release reporting that Takeda Global Research & Development Center Inc, its wholly-owned US subsidiary, has received a complete response letter from the US Food and...

NovaDel receives commitment of investment fund to purchase up to 13 M shares over the next 12 months.
June 29, 2009... NovaDel Pharma Inc (NovaDel) entered into an agreement with Seaside 88 LP (Seaside). Under the terms of the agreement and subject to the approval of the NYSE AMEX, Seaside has committed to purchase up to 13 M NovaDel common shares, in a...

Dr N Joseph Espat presented positive clinical results on the use of biologics for abdominal wall reconstruction in chemotherapy patients.
June 29, 2009... Dr N Joseph Espat MD, MS, FACS presented favourable results of biologic materials, specifically Cook Medical's Biodesign, for the treatment of abdominal wall wounds complicated from chemotherapy, at the Abdominal Wall Reconstruction...

Abraxane approved for advanced breast cancer patient treatment in Quebec.
June 29, 2009... Abraxis BioScience Inc (Abraxis) announced the listing of Abraxane for Injectable Suspension (paclitaxel protein-bound particles for injectable suspension) (albumin-bound) 100 mg in Quebec for the treatment of metastatic breast cancer with a...

CytRx reports favourable progress update for its pivotal Phase II clinical trial with tamibarotene as a third-line treatment for acute promyelocytic leukaemia.
June 29, 2009... CytRx Corp provided a favourable progress update for its ongoing Phase II STAR-1 registration clinical trial to evaluate the efficacy and safety of orally administered tamibarotene as a third-line treatment for acute promyelocytic leukaemia...

BioSante Pharmaceuticals comments on study showing no increased risk of breast cancer in women using testosterone for low libido.
June 29, 2009... BioSante Pharmaceuticals Inc, which is developing a testosterone gel (LibiGel) to treat hypoactive sexual desire disorder (HSDD) in women, is pleased to comment on results in a paper published in the Jul issue of The Journal of Sexual...

ImmunoCellular Therapeutics announces issuance of Japanese patent covering its lead antibody product candidate ICT-109 for treatment of small cell lung cancer.
June 29, 2009... ImmunoCellular Therapeutics Ltd (IMUC), a clinical-stage biotechnology company that is developing immune based therapies for the treatment of brain and other cancers, announced the issuance of a Japanese patent relating to the company's...

Teva and Antares announce FDA approval of needle-free injector product for administration of Tev-Tropin (human growth hormone).
June 29, 2009... Teva Pharmaceutical Industries Ltd and its partner, Antares Pharma Inc announced the approval of a Supplemental New Drug Application (sNDA), which added 'needle-free injection' to its Tev-Tropin [somatropin (rDNA) for injection] brand human...

Rexahn Pharmaceuticals signs development and commercialisation agreement with a top 20 pharmaceutical company for novel anti-cancer compound.
June 29, 2009... Rexahn Pharmaceuticals Inc, a clinical stage pharmaceutical company commercialising potential best in class oncology and CNS therapeutics, announced that it has signed an exclusive collaboration and option for licence agreement with a top 20...

Celera Grants licence to Bayer Schering Pharma for cancer-related targets.
June 29, 2009... Celera Corporation announced an exclusive licence agreement with Bayer Schering Pharma AG, providing Bayer Schering Pharma with access to five cancer-related targets for therapeutic development and in-vivo diagnostic imaging. These...

Cold is cool: European campaign to turn down the heat on washing machines.
June 29, 2009... Doing laundry is one of the most energy-intensive household processes in Europe and the US. But it does not have to be that way. Consumers could often just turn down the dial on their washing machines and still get clean clothes, save money...

Politicians to drive on straw-based bioethanol at the Climate Change Conference.
June 29, 2009... When the politicians are being transported all over Copenhagen during the United Nations Climate Change Conference in Dec 2009, environmentally friendly fuel will also be used. Assisted by Partnership for Biofuels, a co-operation between...

Palatin Technologies (PTN) to buy some products from Wyeth (WYE).
June 29, 2009... Paladin Labs Inc has entered into an agreement with Wyeth to acquire a bundle of products currently marketed in Canada by Wyeth that includes Anacin (acetylsalicylic acid) and Anbesol (benzocaine). Canadian net sales of the portfolio of...

DuoCort AB: New chronotherapy for adrenal insufficiency.
June 29, 2009... DuoCort publishes data from its Phase I study for the rare and life threatening disease adrenal insufficiency. The release profile of DuoCorts new form of treatment with once-a-day hydrocortisone dosing closely resembles the physiological...

OctoPlus' licensee Biolex Therapeutics completes patient enrollment in Phase IIb study with Locteron.
June 29, 2009... OctoPlus NV ("OctoPlus") announces that its licensee Biolex Therapeutics has completed patient enrollment in its SELECT-2 Phase IIb clinical study of Locteron, a controlled release formulation of interferon alpha for the treatment of chronic...

Ablynx announces a novel preclinical development candidate targeting Il6r.
June 29, 2009... Ablynx has advanced ALX-0061, a new Nanobody-based therapeutic programme, into preclinical development for the treatment of autoimmune and inflammatory diseases. ALX-0061 is a selective, low molecular weight biologic, binding to the IL6...

HanAll Pharmaceutical Co Ltd acquires global rights to Nautilus Biotechs protein engineering technology for developing novel oral and injectable therapeutic proteins.
June 29, 2009... HanAll Pharmaceutical Co Ltd announced that the company has been awarded global and exclusive ownership to all patents, data and documentation related to Nautilus Biotechs high-speed throughput protein engineering technology and products....

Evotec announces the successful completion of the first Phase I study with EVT 401, an oral P2X7 receptor antagonist - very good safety profile and confirmed 'On Target Activity'.
June 29, 2009... Evotec AG announced the successful completion of the first Phase I study with its P2X7 receptor antagonist EVT 401. EVT 401 is a small molecule drug candidate and a potentially novel approach to orally treat inflammatory conditions such as...

Amarillo Biosciences and CytoPharm announce start of enrollment for hepatitis C study in Taiwan.
June 29, 2009... Amarillo Biosciences Inc (ABI) and CytoPharm Inc jointly announced the start of enrollment for a study of ABI's oral interferon-alpha lozenges for chronic hepatitis C virus infection. The aim of the trial is to reduce the virologic relapse...

Achillion announces first-in-human dosing of ACH-1625 for treatment of hepatitis C.
June 29, 2009... Achillion Pharmaceuticals Inc has begun dosing in a Phase I clinical trial of ACH-1625, a protease inhibitor for the treatment of hepatitis C virus (HCV) infection. The Phase I clinical trial is a randomised, double-blind, placebo-controlled...

UCB brings Neupro back to all patients in Europe.
June 29, 2009... UCB announced that Neupro (rotigotine transdermal patch) can now be prescribed to all patients with idiopathic Parkinson's disease in Europe and is newly available for the symptomatic treatment of moderate to severe idiopathic Restless Legs...

Lorus Therapeutics Inc announces publication of a novel analytical method confirming the pharmacological action of its anticancer drug LOR-2040.
June 29, 2009... Lorus Therapeutics Inc (Lorus) announced a publication from investigators at the Ohio State University (OSU). The article entitled "A LC-MS/MS Method for the Analysis of Intracellular Nucleoside Triphosphate Levels" was published in the...

Innovative Biopharmaceutical Company, Domainex Ltd, announces asthma treatment collaboration with St George's Hospital Medical School and the University of Manchester.
June 29, 2009... Domainex Ltd, St Georges University of London, and The University of Manchester, are collaborating on a new drug discovery programme to provide a better treatment for asthma. Domainex, specialists in drug discovery solutions, will provide...

Protox Therapeutics Inc to present benign prostatic hyperplasia data at Canadian Urology Conference.
June 29, 2009... Protox Therapeutics Inc, a leader in the development of receptor targeted fusion proteins, announced that data from their open label Phase II clinical study of PRX302 in patients with moderate to severe benign prostatic hyperplasia (BPH),...

Innate Pharma reports positive Phase IIa clinical results for Iph 1101 in type C viral hepatitis.
June 29, 2009... Innate Pharma reports positive results for its first Phase IIa clinical trial with IPH 1101 (a small-molecule ?d T cell agonist) in patients with type C viral hepatitis ("HCV"). IPH 1101-203 was a multi-centre, open label Phase IIa clinical...

Generex sees favourable results from MetControl chewing gum bio-equivalency study leading to global product submissions.
June 29, 2009... Generex Biotechnology Corp has reviewed the positive data from its bioequivalent study with MetControl, its proprietary metformin chewing gum product study conducted in Nov 2008. Results of the fully compliant ICH-GCP conducted study indicate...

MorphoSys AG announces clinical milestone in therapeutic antibody programme.
June 29, 2009... Seventh HuCAL Antibody to Enter Clinical Trials MorphoSys AG announced that it will receive a milestone payment from Centocor Ortho Biotech Inc (formerly known as: Centocor Inc) in connection with the initiation of a Phase I clinical trial...

Dow announces plan to build and operate a pilot-scale algae-based integrated biorefinery with Algenol Biofuels.
June 29, 2009... The Dow Chemical Co (Dow) announced that it plans to work with Algenol Biofuels Inc (Algenol) to build and operate a pilot-scale algae-based integrated biorefinery that will convert CO2 into ethanol. The facility is planned to be located at...

A Schulman announces closing of invision sheet manufacturing operation at Sharon Center, OH plant.
June 29, 2009... A Schulman Inc announced that on Thursday, 25 Jun 2009, its board of directors approved a plan to cease the operation of its Invision sheet production line at its Sharon Center, OH manufacturing facility, by the end of 4Q 2009. A total of...

Frost & Sullivan recognizes NeXolve for superior polymer product.
June 29, 2009... Based on its recent analysis of the field of nanocomposites for space applications, Frost & Sullivan recognizes NeXolve Corp, a wholly-owned subsidiary of ManTech International Corp, with the 2009 North American Frost & Sullivan Award for...

Centocor Ortho Biotech Inc awarded $1.67 bn patent jury verdict from Abbott Laboratories.
June 29, 2009... Centocor Ortho Biotech Inc (Centocor) announced that a federal jury has returned a verdict of $1.67 bn against Abbott Laboratories in a patent infringement suit. The patent in question relates to the company's anti-TNF class of arthritis...

CCA Industries Inc declares $0.07 dividend for 3Q 2009 payable on 3 Sep 2009.
June 29, 2009... CCA Industries Inc announced that its Board of Directors declared a $0.07 cash dividend payable to all shareholders of record 3 Aug 2009 payable on 3 Sep 2009, the twentieth consecutive dividend paid by the company. The $0.07 dividend was...

Adventrx Pharmaceuticals announces financing.
June 29, 2009... Adventrx Pharmaceuticals Inc (Adventrx) has obtained a commitment to purchase shares of its 5% Series B convertible preferred stock pursuant to a registered direct offering to a single institutional investor, representing gross proceeds of...

Hospira receives FDA approval for azithromycin for injection.
June 29, 2009... Hospira Inc has received US Food and Drug Administration (FDA) approval for a 500 mg vial of azithromycin for injection in the ADD-Vantage System. The anti-infective medication is a generic version of Pfizer's Zithromax for injection. The US...

Lotus Pharmaceuticals Inc again awarded GSP certification.
June 29, 2009... Lotus Pharmaceuticals Inc received a Good Supply Practices (GSP) certificate from the Chinese State Food & Drug Administration (SFDA) for the second time since 2003. Liang Fang Pharmaceutical Ltd, operated by Lotus Pharmaceuticals, passed the...

Access Pharmaceuticals announces commercial launch of MuGard in Greece by SpePharm.
June 29, 2009... Access Pharmaceuticals Inc (Access) announced that its European partner, SpePharm has commenced commercial launch of MuGard in Greece. This follows previous commercial launches in Germany, Italy and the UK. Under a licence from Access...

AdventRx Pharmaceuticals announces plans for remainder of 2009.
June 29, 2009... AdventRx Pharmaceuticals Inc (AdventRx) announced its plans for the remainder of 2009. Following the financing that closed earlier in Jun 2009, AdventRx has re-started the final manufacturing activities related to submitting an NDA for...

Yaupon Therapeutics completes patient enrolment for pivotal Phase II study of Clearazide for treatment of cutaneous T-cell lymphoma.
June 29, 2009... Yaupon Therapeutics (Yaupon) has completed enrolment for a pivotal Phase II clinical trial for Clearazide for the treatment of early-stage cutaneous T-cell lymphoma (CTCL - stages 1-2a). The study, which is being conducted under a Special...